Role of nitric oxide in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice

Journal of Virology

Volumn 83, Issue 16, 2009, Pages 8004-8011

  Lee, Young Sun ^a   Li, Na ^b   Shin, Seungjin ^b   Jun, Hee Sook ^a  

^a Gachon University College of Medicine   (South Korea)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN CIAP 1; PROTEIN CIAP 2; PROTEIN MCL 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; ENCEPHALOMYOCARDITIS VIRUS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULITIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET CELL TUMOR; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CARDIOVIRUS INFECTIONS; CELLS, CULTURED; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; HUMANS; INSULIN-SECRETING CELLS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

ENCEPHALOMYOCARDITIS VIRUS; MUS;

EID: 67749142253     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00205-09     Document Type: Article

References (39)

1. Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326.
2. Andersson, A. K., M. Flodstrom, and S. Sandler. 2001. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase. Biochem. Biophys. Res. Commun. 281:396-403.
3. Araki, E., S. Oyadomari, and M. Mori. 2003. Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus. Exp. Biol. Med. 228:1213-1217.
4. Baek, H. S., and J. W. Yoon. 1991. Direct involvement of macrophages in destruction of beta-cells leading to development of diabetes in virus-infected mice. Diabetes 40:1586-1597.
5. Baek, H. S., and J. W. Yoon. 1990. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 64:5708-5715.
6. Baldwin, A. S., Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
7. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916.
8. Borjesson, A., A. K. Andersson, and S. Sandler. 2006. Survival of an islet allograft deficient in iNOS after implantation into diabetic NOD mice. Cell Transplant. 15:769-775.
9. Croen, K. D. 1993. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Investig. 91:2446-2452.
10. Flodstrom, M., B. Tyrberg, D. L. Eizirik, and S. Sandler. 1999. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48:706-713.
11. Green, D. R. 2000. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102:1-4.
12. Guler, R., M. L. Olleros, D. Vesin, R. Parapanov, C. Vesin, S. Kantengwa, L. Rubbia-Brandt, N. Mensi, A. Angelillo-Scherrer, E. Martinez-Soria, F. Tacchini-Cottier, and I. Garcia. 2004. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41:773-781.
13. Hirasawa, K., H. S. Jun, H. S. Han, M. L. Zhang, M. D. Hollenberg, and J. W. Yoon. 1999. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages. J. Virol. 73:8541-8548.
14. Hirasawa, K., H. S. Jun, K. Maeda, Y. Kawaguchi, S. Itagaki, T. Mikami, H. S. Baek, K. Doi, and J. W. Yoon. 1997. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 71:4024-4031.
15. Hirasawa, K., M. Takeda, S. Itagaki, and K. Doi. 1996. Involvement of macrophages in the development of encephalomyocarditis (EMC) virus-induced diabetes in mice. Exp. Anim. 45:77-80.
16. Hirasawa, K., S. Tsutsui, M. Takeda, M. Mizutani, S. Itagaki, and K. Doi. 1996. Depletion of Mac1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes. J. Gen. Virol. 77:737-741.
17. Jun, H. S., C. S. Yoon, L. Zbytnuik, N. van Rooijen, and J. W. Yoon. 1999. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 189:347-358.
18. Jun, H. S., and J. W. Yoon. 2001. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 44:271-285.
19. Kaneto, H., J. Fujii, H. G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, and N. Taniguchi. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44:733-738.
20. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
21. Karlsen, A. E., H. U. Andersen, H. Vissing, P. M. Larsen, S. J. Fey, B. G. Cuartero, O. D. Madsen, J. S. Petersen, S. B. Mortensen, T. Mandrup-Poulsen, et al. 1995. Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 44:753-758.
22. Lindsay, R. M., W. Smith, S. P. Rossiter, M. A. McIntyre, B. C. Williams, and J. D. Baird. 1995. N-omega-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44:365-368.
23. -/-). Diabetes 49:1116-1122.
24. Mannick, J. B. 1995. The antiviral role of nitric oxide. Res. Immunol. 146:693-697.
25. McKenzie, M. D., E. M. Carrington, T. Kaufmann, A. Strasser, D. C. Huang, T. W. Kay, J. Allison, and H. E. Thomas. 2008. Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells. Diabetes 57:1284-1292.
26. Meier, P., A. Finch, and G. Evan. 2000. Apoptosis in development. Nature 407:796-801.
27. Mendez, I. I., Y. H. Chung, H. S. Jun, and J. W. Yoon. 2004. Immunoregulatory role of nitric oxide in Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J. Immunol. 173:1327-1335.
28. Messmer, U. K., U. K. Reed, and B. Brune. 1996. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J. Biol. Chem. 271:20192-20197.
29. Oyadomari, S., K. Takeda, M. Takiguchi, T. Gotoh, M. Matsumoto, I. Wada, S. Akira, E. Araki, and M. Mori. 2001. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl. Acad. Sci. USA 98:10845-10850.
30. Piro, S., M. Anello, C. Di Pietro, M. N. Lizzio, G. Patane, A. M. Rabuazzo, R. Vigneri, M. Purrello, and F. Purrello. 2002. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51:1340-1347.
31. Stassi, G., R. De Maria, G. Trucco, W. Rudert, R. Testi, A. Galluzzo, C. Giordano, and M. Trucco. 1997. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1193-1200.
32. Steer, S. A., A. L. Scarim, K. T. Chambers, and J. A. Corbett. 2006. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med. 3:e17.
33. Takamura, T., I. Kato, N. Kimura, T. Nakazawa, H. Yonekura, S. Takasawa, and H. Okamoto. 1998. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. J. Biol. Chem. 273:2493-2496.
34. Thomas, D., H. Yang, D. J. Boffa, R. Ding, V. K. Sharma, M. Lagman, B. Li, B. Hering, T. Mohanakumar, J. Lakey, S. Kapur, W. W. Hancock, and M. Suthanthiran. 2002. Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation 74:1489-1496.
35. Utsugi, T., M. Nagata, T. Kawamura, and J. W. Yoon. 1994. Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes. Transplantation 57:1799-1804.
36. Yoon, J. W., and H. S. Jun. 2006. Viruses cause type 1 diabetes in animals. Ann. N. Y. Acad. Sci. 1079:138-146.
37. Yoon, J. W., P. R. McClintock, T. Onodera, and A. L. Notkins. 1980. Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J. Exp. Med. 152:878-892.
38. Yoon, J. W., A. K. Wong, Y. S. Bae, and H. M. Eun. 1988. An apparent deletion of an oligonucleotide detected by RNA fingerprint in the nondiabetogenic B variant of encephalomyocarditis virus is caused by a point mutation. J. Virol. 62:637-640.
39. Zaragoza, C., C. J. Ocampo, M. Saura, A. McMillan, and C. J. Lowenstein. 1997. Nitric oxide inhibition of coxsackievirus replication in vitro. J. Clin. Investig. 100:1760-1767.